(Press-News.org) The warm beauty of amber was captivating and mysterious enough to inspire myths in ancient times, and even today, some of its secrets remain locked inside the fossilized tree resin. But for the first time, scientists have now solved at least one of its puzzles that had perplexed them for decades. Their report on a key aspect of the gemstone's architecture appears in the ACS journal Analytical Chemistry.
Jennifer Poulin and Kate Helwig of the Canadian Conservation Institute point out that much of the amber we see today had its origins millions of years ago, when it exuded from trees and then fossilized over time. Some of the oldest recovered samples even predate the rise of dinosaurs — and could outlast even the most advanced materials that science can make today. But it's exactly that extreme durability that has made amber's internal structure so difficult to understand. Scientists have used one particular technique to probe the inner molecular architecture of the ancient resin, but the process seemed to destroy evidence of certain relationships between compounds. Poulin and Helwig decided to try a new approach.
Building on past attempts using something called pyrolysis-gas chromatography-mass spectrometry, they slowed down the pyrolysis phase, which essentially uses heat to break down a substance. By doing so, the researchers were able to show that specific groups of atoms within their samples were bound to succinic acid, known historically as "spirit of amber." "There can be no doubt that much of the stability and durability of certain kinds of amber comes from the succinic acid cross-linking within the matrix," the researchers said.
INFORMATION:
The American Chemical Society is a nonprofit organization chartered by the U.S. Congress. With more than 161,000 members, ACS is the world's largest scientific society and a global leader in providing access to chemistry-related research through its multiple databases, peer-reviewed journals and scientific conferences. Its main offices are in Washington, D.C., and Columbus, Ohio.
To automatically receive news releases from the American Chemical Society, contact newsroom@acs.org.
Follow us: Twitter Facebook
One secret of ancient amber revealed
2014-07-09
ELSE PRESS RELEASES FROM THIS DATE:
Sunshine vitamin ups bowel cancer survival odds, study finds
2014-07-09
Bowel cancer patients with high levels of vitamin D in their blood are more likely to survive the disease, a study shows.
Patients with the highest levels of vitamin D have half the risk of dying compared with those with the lowest levels, the findings reveal.
The study is the first to correlate total blood levels of vitamin D in bowel cancer patients after their diagnosis – which includes that produced after exposure to sunlight and that obtained from dietary sources – with their long term survival prospects.
The University of Edinburgh team tested blood samples ...
Short circuit in the food web
2014-07-09
Jena (Germany) They are amongst the most numerous inhabitants of the sea: tiny haptophytes of the type Emiliania huxleyi. Not visible to the naked eye, when they are in bloom in spring, they form square kilometer sized patches, they are even visible on satellite images. "Together with other phytoplankton, Emiliania huxleyi is responsible for approximately half of the global photosynthesis output," states Prof. Dr. Georg Pohnert of the Friedrich Schiller University Jena (Germany). In the process the greenhouse gas carbon dioxide – CO2 – is extracted from the atmosphere and ...
Fit for the frontline? New study identifies the hearing requirements of British soldiers
2014-07-09
AUDIO:
The gunshot is a binaural recording using KEMAR, the weapon was an SA80 assault rifle and the microphone is 50m downrange from the firer and approximately 30cm from the bullet...
Click here for more information.
University of Southampton researchers, with assistance from the Ministry of Defence, have conducted the first study to identify the hearing requirements of British soldiers fighting on the frontline.
The study, which provides an important and novel insight into ...
Even geckos can lose their grip
2014-07-09
Not even geckos and spiders can sit upside down forever. Nanophysics makes sure of that. Mechanics researchers at Linköping University have demonstrated this in an article just published in Physical Review E. Knowledge that can be of great industrial benefit.
Geckos and spiders that seem to be able to sit still forever, and walk around upside down have fascinated researchers worldwide for many years. We will soon be able to buy smart new fasteners that hold the same way as the gecko's foot. But the fact is, sooner or later the grip is lost, no matter how little force ...
Frogs have developed rapid defences against the red swamp crayfish
2014-07-09
The common frog is one of the amphibians with the highest distribution in the Iberian Peninsula. It reproduces preferably in permanent areas of water where it comes into contact with the red swamp crayfish, which preys on its larvae. Research carried out by the Spaniard Germán Orizaola from the University of Uppsala (Sweden) confirms that the larvae of these frogs have developed a defensive response to the invasive species. They also have deeper tails and larger bodies if they co-exist with the crayfish.
Numerous invasive organisms are currently spreading outside of their ...
RUB chemists develop novel catalyst with 2 functions
2014-07-09
Chemists at the Ruhr-Universität Bochum have made a decisive step towards more cost-efficient regenerative fuel cells and rechargeable metal-air batteries. They developed a new type of catalyst on the basis of carbon, which can facilitate two opposite reactions: electrolysis of water and combustion of hydrogen with oxygen. A catalyst of this kind might make the storage of wind and solar energy and the manufacture of cost-efficient batteries, for example for electric cars, possible. The team published their report in the "International Edition" of the magazine "Angewandte ...
Rotten egg gas holds key to healthcare therapies
2014-07-09
It may smell of flatulence and have a reputation for being highly toxic, but when used in the right tiny dosage, hydrogen sulfide is now being being found to offer potential health benefits in a range of issues, from diabetes to stroke, heart attacks and dementia. A new compound (AP39), designed and made at the University of Exeter, could hold the key to future therapies, by targeting delivery of very small amounts of the substance to the right (or key) places inside cells.
Scientists in Exeter have already found that the compound protects mitochondria – the "powerhouse" ...
NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection
2014-07-09
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial of CRS3123, an investigational oral antibiotic intended to treat Clostridium difficile (C. difficile) infection. CRS3123 (previously known as REP3123) is a narrow-spectrum agent that inhibits C. difficile growth while sparing normal intestinal bacteria.
The Phase I trial will enroll up to 30 healthy men and women ages 18 to 45 in a dose-escalation study to evaluate the investigational drug's safety and tolerability. Quintiles, ...
The impact of big data on health care: Health Affairs' July issue
2014-07-09
Big data can yield big savings, if they are used in the right ways. David W. Bates of the Brigham and Women's Hospital and coauthors analyzed six use cases with strong opportunities for cost savings—high-cost patients; readmissions; triage; decompensation (when a patient's condition worsens); adverse events; and treatment optimization when a disease affects multiple organ systems. They suspect that cost-savings benefits will vary widely, though the current costs associated with all six scenarios will be significant. The authors suggest that using analytics for multiple ...
Discovery of new drug targets for memory impairment in Alzheimer's disease
2014-07-09
VIDEO:
This is a movie showing how the reactive astrocytes in the brains of Alzheimer's disease model produce the inhibitory transmitter GABA by the enzyme MAO-B and release GABA through the...
Click here for more information.
Alzheimer's disease, which is the most common cause of dementia, is fatal and currently, there is no cure. In Alzheimer's disease, brain cells are damaged and destroyed, leading to devastating memory loss. It is reported that 1 in 8 Americans aged 65 or over ...